Jump to content

US & China ramp up tensions - EMEA brief 07 Aug


JamesIG

1,525 views

  • The Asia equity market ex-Japan are looking at their lowest levels since July last year.
  • Tech sector as a whole was hit by a drop in chip stocks yesterday as well as a knock to social media.
  • Investors are cautious that new U.S. tariffs on China could come into play at any time.
  • Yen and Swiss franc are looking to be bid up for those looking at safe harbours.
  • Non-farm payrolls are out later today.

Asian overnight: Yet again trade concerns weighed on Asian markets, with the Hang Seng posting its worst week since February. Tech stocks remain under pressure in both the US and China, with the momentum trade in the Nasdaq seeing a stark turnaround. A rise in US gasoline reserves hit oil prices and helped drive energy stocks lower.

UK, US and Europe: Yesterday’s ADP numbers were weaker than forecast, so there will be some nervousness among dollar bulls ahead of NFPs this afternoon, while before this we have eurozone GDP figures. Trade war concerns remain front and centre, as the US and China ramp up the tensions.

Economic calendar - key events and forecast (times in BST)

2018-09-07 08_04_48-Inbox - James.Perry@ig.com - Outlook.png

Source: Daily FX Economic Calendar

10am – eurozone GDP (Q2): expected to be 0.4% QoQ and 2.2% YoY, from 0.4% and 2.5% respectively. Market to watch: EUR crosses

1.30pm – US non-farm payrolls (August): NFPs expected to come in at 187K from 157K, while the unemployment rate holds at 3.9%. Average hourly earnings to be 0.3% MoM, in line with last month. Markets to watch: US indices, USD crosses

1.30pm – Canada employment data (August): 15,900 jobs forecast to have been created, from 54,100 a month earlier. Market to watch: CAD crosses

Corporate News, Upgrades and Downgrades

  • Playtech said that it has sold its 10% stake in Plus500 for £176 million. The proceeds will be used or general corporate purposes and to reduce net debt. 
  • AstraZeneca said that the FDA had granted a breakthrough therapy label for its asthma treatment. 

Aixtron upgraded to hold at Baader Helvea
BioMerieux upgraded to buy at Kepler Cheuvreux
Equinor upgraded to buy at SEB Equities
Idorsia upgraded to hold at Berenberg

Burberry cut to neutral at Goldman
MorphoSys downgraded to hold at Berenberg
Safran downgraded to hold at SocGen
Shire downgraded to hold at Berenberg

IGTV featured video

Information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.  

1 Comment


Recommended Comments

is it just me that gets bugged by the IGTV youtube videos which are seriously left aligned in their white texts? like .... plz just indent it a little :D:D so the spacing on the left is the same as the bottom...

 

Link to comment

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...
us